-
Exploring the brainstem functions in cervical dystonia
-
Exploring therapeutic viability of a non-dopaminergic target for Parkinson’s disease
-
Extended-release carbidopa-levodopa, IPX066: Dosing and efficacy with concomitant medication use in Parkinson’s disease
-
Extensive bilateral basal ganglia and cerebellar calcification in Fahr’s syndrome after thyroidectomy
-
Eye movement abnormalities in essential tremor and other neurodegenerative diseases (Parkinson’s disease, spino-cerebellar ataxia, Huntington disease)
-
Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases
-
F1 crossbreds of C57BL/6 and CD-1 mice demonstrate resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induced nigral neurodegeneration
-
Face and color recognition after subthalamic nucleus stimulation in Parkinson’s disease
-
Facial expressivity in Parkinson’s disease (PD) via an examination of smiling behavior: Preliminary findings
-
Factors affecting the cardiac sympathetic denervation in autopsy confirmed dementia with Lewy bodies
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 207
- Next Page »